Here are what the editors at HealthDay consider to be the most important developments in Critical Care for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
AMA Announces Initiative to Reinvent Physician Training
TUESDAY, Oct. 30, 2018 (HealthDay News) — The American Medical Association (AMA) today announced a new $15 million competitive grant initiative, the “Reimagining Residency” initiative, aimed at improving residency training.
Many Hospitals Noncompliant With Record Request Regulations
MONDAY, Oct. 29, 2018 (HealthDay News) — Among top-ranked U.S. hospitals, data reveal discrepancies in information provided to patients regarding medical records release processes as well as noncompliance with state and federal regulations, according to a study published online Oct. 5 in JAMA Network Open.
In Complicated UTI, Cefiderocol Noninferior to Imipenem-Cilastin
MONDAY, Oct. 29, 2018 (HealthDay News) — For complicated urinary tract infections caused by multidrug-resistant Gram-negative uropathogens, the siderophore cephalosporin cefiderocol is non-inferior to imipenem-cilastatin, according to a study published online Oct. 25 in The Lancet Infectious Diseases.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Trump Administration Announces Plan to Cut Drug Prices
FRIDAY, Oct. 26, 2018 (HealthDay News) — In an effort to cut high drug costs, the prices paid by Medicare for certain prescription drugs would be based on those in other advanced industrial nations, according to a proposal announced Oct. 25 by the Trump administration.
HHS Study
New York Times Article
Oxygen Saturation Should Not Top 96 Percent in Acutely Ill
THURSDAY, Oct. 25, 2018 (HealthDay News) — For acutely ill patients, an oxygen saturation of no more than 96 percent should be maintained, according to a clinical practice guideline published online Oct. 24 in the BMJ.
Neither Haloperidol, Ziprasidone Shortens Delirium in ICU
THURSDAY, Oct. 25, 2018 (HealthDay News) — For patients with acute respiratory failure or shock and hypoactive or hyperactive delirium in the intensive care unit, neither haloperidol nor ziprasidone alters the duration of delirium compared with placebo, according to a study published online Oct. 22 in the New England Journal of Medicine.
Pace of Change Has Accelerated in Alternative Payment Models
THURSDAY, Oct. 25, 2018 (HealthDay News) — The impact of alternative payment models (APMs) on physician practices has been described in a study published by the RAND Corp. and the American Medical Association.
Myo-Inositol Does Not Reduce Retinopathy of Prematurity
NEWS2 Scores Can ID Patients With Suspected Sepsis Needing Timely Treatment .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
Therapeutic Hypothermia Duration Explored in Comatose OHCA Survivors 
Autonomous Oxygen Titration Increases Proportion of Time in Normoxemia 
High-Dose Intravenous Vitamin C May Benefit Trauma Patients 
2011 to 2023 Saw Rise in Discharges to Hospice After ICU Admission 
Odds of Adverse Patient Outcomes Increased for Patients With Duplicate Medical Charts 
Weekly, High-Risk Rounds Reduced Hospital-Acquired Conditions in Pediatric ICU 
